These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 9717054

  • 1. Rationale for ACE inhibition as an anti-ischaemic therapy.
    Pepine CJ.
    Eur Heart J; 1998 Jul; 19 Suppl G():G34-40. PubMed ID: 9717054
    [Abstract] [Full Text] [Related]

  • 2. Ischemia Management with Accupril post bypass Graft via Inhibition of angiotensin coNverting enzyme (IMAGINE): a multicentre randomized trial - design and rationale.
    Warnica JW, Gilst WV, Baillot R, Johnstone D, Block P, Myers MG, Chocron S, Ave SD, Martineau P, Rouleau JL.
    Can J Cardiol; 2002 Nov; 18(11):1191-200. PubMed ID: 12464983
    [Abstract] [Full Text] [Related]

  • 3. The sympathetic nervous system and ischaemic heart disease.
    Remme WJ.
    Eur Heart J; 1998 Jun; 19 Suppl F():F62-71. PubMed ID: 9651738
    [Abstract] [Full Text] [Related]

  • 4. Effect of ACE inhibition on neurohormones.
    Remme WJ.
    Eur Heart J; 1998 Sep; 19 Suppl J():J16-23. PubMed ID: 9796836
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function Ischemia Management with Accupril post-bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the other major trials in coronary artery disease.
    van Gilst WH, Warnica JW, Baillot R, Johnstone D, Calciu CD, Block P, Myers MG, Chocron S, Rouleau JL, IMAGINE Investigators.
    Am Heart J; 2006 Jun; 151(6):1240-6. PubMed ID: 16781228
    [Abstract] [Full Text] [Related]

  • 6. BANFF: an update.
    Anderson T.
    Can J Cardiol; 1999 Apr; 15 Suppl B():29B-30B. PubMed ID: 10350682
    [Abstract] [Full Text] [Related]

  • 7. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
    Tschudi MR, Noll G, Lüscher TP.
    Schweiz Med Wochenschr; 1997 Apr 12; 127(15):636-49. PubMed ID: 9198890
    [Abstract] [Full Text] [Related]

  • 8. [Hypertensive patients with signs of coronary heart disease. An ACE inhibitor improves endothelial function].
    MMW Fortschr Med; 2001 Aug 23; 143(33-34):58-9. PubMed ID: 11561465
    [No Abstract] [Full Text] [Related]

  • 9. Acute effects of ACE inhibition on coronary endothelial dysfunction.
    Nickenig G, Stäblein A, Wassmann S, Wyen C, Müller C, Böhm M.
    J Renin Angiotensin Aldosterone Syst; 2000 Dec 23; 1(4):361-4. PubMed ID: 11967824
    [Abstract] [Full Text] [Related]

  • 10. Effect of ACE inhibition on myocardial ischaemia.
    Ferrari R.
    Eur Heart J; 1998 Sep 23; 19 Suppl J():J30-5. PubMed ID: 9796838
    [Abstract] [Full Text] [Related]

  • 11. Potential role of angiotensin-converting enzyme inhibition in myocardial ischemia and current clinical trials.
    Pepine CJ.
    Clin Cardiol; 1997 Nov 23; 20(11 Suppl 2):II-58-64. PubMed ID: 9422854
    [Abstract] [Full Text] [Related]

  • 12. Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure.
    Hornig B, Arakawa N, Drexler H.
    Eur Heart J; 1998 Jul 23; 19 Suppl G():G48-53. PubMed ID: 9717056
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The significance of converting enzyme inhibitor angiotensin I to angiotensin II in treatment of patients with coronary disease].
    Halawa B.
    Pol Merkur Lekarski; 1998 Jan 23; 4(19):32-4. PubMed ID: 9553407
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin-converting enzyme inhibitors in patients with atherosclerosis and preserved left ventricular function: clinical outcomes.
    Pepine C.
    Can J Cardiol; 1998 Jul 23; 14 Suppl D():23D-26D. PubMed ID: 9713427
    [No Abstract] [Full Text] [Related]

  • 17. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
    Hlubocká Z, Umnerová V, Heller S, Peleska J, Jindra A, Jáchymová M, Kvasnicka J, Horký K, Aschermann M.
    J Hum Hypertens; 2002 Aug 23; 16(8):557-62. PubMed ID: 12149661
    [Abstract] [Full Text] [Related]

  • 18. Towards 2001: will ACE inhibitors have a role in atherosclerosis treatment?
    Sharpe N.
    Int J Clin Pract Suppl; 1998 May 23; 94():26-31. PubMed ID: 9926442
    [Abstract] [Full Text] [Related]

  • 19. Effects of perindopril on long-term clinical outcome of patients with coronary artery disease and preserved left ventricular function.
    Bertrand ME, Remme WJ, Fox KM, Ferrari R, Simoons ML, EUROPA investigators.
    Int J Cardiol; 2007 Sep 14; 121(1):57-61. PubMed ID: 17270296
    [Abstract] [Full Text] [Related]

  • 20. [New aspects of ACE inhibitor treatment of heart failure].
    Dietz R, Osterziel KJ.
    Z Kardiol; 1996 Sep 14; 85 Suppl 6():241-6. PubMed ID: 9064971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.